Great West Life Assurance CO Incyte Corp Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

A detailed history of Great West Life Assurance CO transactions in Incyte Corp stock. As of the latest transaction made, Great West Life Assurance CO holds 177,314 shares of INCY stock, worth $12.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

177,314

Previous 182,657 2.93%

Holding current value

$12.3 Million

Previous $11.1 Million 5.92%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$57.33 - $68.61 $306,314 - $366,583	-5,343 Reduced 2.93%	177,314 $11.7 Million
Q2 2024 Aug 12, 2024	BUY	$51.18 - $63.75 $208,507 - $259,717	4,074 Added 2.28%	182,657 $11.1 Million
Q1 2024 May 13, 2024	SELL	$56.55 - $66.59 $1.76 Million - $2.07 Million	-31,115 Reduced 14.84%	178,583 $10.2 Million
Q4 2023 Feb 13, 2024	SELL	$52.16 - $64.19 $800,082 - $984,610	-15,339 Reduced 6.82%	209,698 $13.1 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $103,292 - $117,882	-1,788 Reduced 0.79%	225,037 $13 Million
Q2 2023 Aug 10, 2023	BUY	$60.95 - $75.51 $2 Million - $2.47 Million	32,764 Added 16.88%	226,825 $14.2 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $1.16 Million - $1.42 Million	16,452 Added 9.26%	194,061 $14.1 Million
Q4 2022 Feb 10, 2023	BUY	$67.18 - $84.11 $695,716 - $871,043	10,356 Added 6.19%	177,609 $14.3 Million
Q3 2022 Nov 01, 2022	BUY	$66.18 - $82.86 $11.1 Million - $13.9 Million	167,253 New	167,253 $11.1 Million
Q2 2022 Aug 09, 2022	BUY	$66.18 - $83.18 $899,253 - $1.13 Million	13,588 Added 8.07%	181,916 $13.8 Million
Q1 2022 May 12, 2022	SELL	$66.02 - $79.71 $2.02 Million - $2.44 Million	-30,578 Reduced 15.37%	168,328 $14.1 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $1.73 Million - $2.02 Million	27,241 Added 15.87%	198,906 $14.6 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $485,771 - $594,357	7,074 Added 4.3%	171,665 $11.9 Million
Q2 2021 Aug 11, 2021	SELL	$79.87 - $87.53 $364,926 - $399,924	-4,569 Reduced 2.7%	164,591 $13.8 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $544,759 - $720,183	7,166 Added 4.42%	169,160 $13.7 Million
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $252,796 - $305,898	-3,131 Reduced 1.9%	161,994 $14 Million
Q3 2020 Nov 17, 2020	SELL	$85.07 - $109.69 $2.27 Million - $2.93 Million	-26,714 Reduced 13.93%	165,125 $0
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $2.12 Million - $2.73 Million	24,874 Added 14.9%	191,839 $0
Q2 2020 Aug 17, 2020	BUY	$74.18 - $108.93 $1.48 Million - $2.17 Million	19,929 Added 13.55%	166,965 $17.3 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $3.1 Million - $4.22 Million	-49,105 Reduced 25.04%	147,036 $10.8 Million
Q4 2019 Feb 11, 2020	BUY	$73.04 - $95.72 $4.06 Million - $5.33 Million	55,632 Added 39.59%	196,141 $0
Q3 2019 Oct 25, 2019	BUY	$72.82 - $86.52 $972,729 - $1.16 Million	13,358 Added 10.51%	140,509 $10.4 Million
Q2 2019 Jul 31, 2019	SELL	$73.52 - $88.7 $287,095 - $346,373	-3,905 Reduced 2.98%	127,151 $0
Q1 2019 May 08, 2019	BUY	$63.56 - $88.17 $1.51 Million - $2.09 Million	23,741 Added 22.12%	131,056 $11.2 Million
Q4 2018 Feb 12, 2019	BUY	$58.5 - $69.94 $39,838 - $47,629	681 Added 0.64%	107,315 $6.5 Million
Q3 2018 Nov 13, 2018	SELL	$61.75 - $74.23 $1.23 Million - $1.48 Million	-19,878 Reduced 15.71%	106,634 $7.37 Million
Q2 2018 Aug 10, 2018	BUY	$60.85 - $83.98 $153,281 - $211,545	2,519 Added 2.03%	126,512 $8.48 Million
Q1 2018 May 10, 2018	BUY	$83.06 - $100.98 $7,807 - $9,492	94 Added 0.08%	123,993 $10.3 Million
Q4 2017 Feb 09, 2018	BUY	$93.56 - $116.6 $194,604 - $242,528	2,080 Added 1.71%	123,899 $11.7 Million
Q3 2017 Nov 09, 2017	BUY	$109.15 - $138.27 $13.3 Million - $16.8 Million	121,819	121,819 $13.8 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.4B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Incyte Corp Transaction History